AI-assisted, human-published
08/25/2026 /M & A
RPC Expands Portfolio with Acquisition of Peracidin® Product Line
RPC successfully acquires the Peracidin® product line from Angelini Pharma, reinforcing its commitment to providing reliable products and uninterrupted supply to healthcare providers worldwide. Angelini Pharma focuses on Brain Health and the Consumer market, operating directly in 20 countries and employing over 3,000 people.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com